BNP Paribas Executes Multi-Stock Deals Worth Rs 3,416 Crore; TPG Exits Sai Life Sciences

1 min read     Updated on 26 Aug 2025, 09:41 PM
scanx
Reviewed by
Riya DeyBy ScanX News Team
whatsapptwittershare
Overview

BNP Paribas Financial Markets conducted bulk deals totaling Rs 3,415.8 crore across multiple Indian companies. Notable transactions include acquiring a 1.05% stake in Eternal Ltd. (Zomato parent) for Rs 3,220 crore, selling shares in Swiggy worth Rs 1,157 crore, and divesting stakes in Waaree Energies, Hitachi Energy, and Vishal Mega Mart. Simultaneously, TPG Asia VII SF Pte sold its entire 14.72% stake in Sai Life Sciences for Rs 2,675 crore, with Goldman Sachs Singapore and Societe Generale as key buyers.

17770290

*this image is generated using AI for illustrative purposes only.

BNP Paribas Financial Markets has made significant moves in the Indian stock market, executing bulk deals across multiple companies totaling Rs 3,415.8 crore. Simultaneously, US private equity firm TPG has completely exited its position in Sai Life Sciences.

BNP Paribas' Strategic Transactions

BNP Paribas Financial Markets engaged in a series of high-value transactions across various companies:

Company Transaction Details
Eternal Ltd. (Zomato parent) - Sold shares worth Rs 51.1 lakh
  • Acquired a 1.05% stake (10.12 crore shares) for Rs 3,220.00 crore | | Swiggy | - Offloaded shares worth Rs 1,157.00 crore
  • Acquired shares worth Rs 18.50 crore | | Waaree Energies | - Sold 17.83 lakh shares (0.62% stake) for Rs 583.00 crore | | Hitachi Energy | - Divested stake for Rs 829.00 crore | | Vishal Mega Mart | - Offloaded shares worth Rs 845.00 crore |

These transactions demonstrate BNP Paribas' active portfolio management strategy, involving both acquisitions and divestments across diverse sectors including food delivery, energy, and retail.

TPG's Exit from Sai Life Sciences

In a separate development, US private equity firm TPG has made a complete exit from Sai Life Sciences:

  • TPG Asia VII SF Pte, an affiliate of TPG, sold its entire 14.72% stake (3.07 crore shares) in Sai Life Sciences.
  • The transaction was valued at Rs 2,675.00 crore, with share prices ranging between Rs 871.01 to Rs 871.86 per share.
  • Notable buyers in this transaction included Goldman Sachs Singapore and Societe Generale.

This exit by TPG marks a significant shift in the ownership structure of Sai Life Sciences and could potentially impact the company's future strategic direction.

Market Implications

These large-scale transactions by BNP Paribas and TPG's exit from Sai Life Sciences highlight the dynamic nature of institutional investments in the Indian market. Such moves can often signal changing market sentiments or strategic realignments by major players.

Investors and market analysts will likely be watching closely to see how these transactions might influence the stock prices and market perceptions of the involved companies in the coming days.

like15
dislike
Explore Other Articles